Articles - Page 76 of 102 - Drugs in Context

Use of botulinum toxin for movement disorders

Carlos Henrique Ferreira Camargo MD, MSc, PhD, Hélio Afonso Ghizoni Teive MD, MSc, PhD

Article Type

Review

Published

18 Jun 2019

The aim of this review is to present the new and well-established uses of botulinum toxin for movement disorders.

Easyhaler®: an overview of an inhaler device for day-to-day use in patients with asthma and chronic obstructive pulmonary disease

Federico Lavorini MD, PhD

Article Type

Review

Published

05 Jun 2019

The aim of this article is to provide an overview of the scientific literature on Easyhaler, with the purpose of emphasising features that make it close to the concept of an ‘ideal’ inhaler for daily use in patients with asthma or chronic obstructive pulmonary disease.

Efficacy and safety of lesinurad for the treatment of hyperuricemia in gout

Fernando Pérez-Ruiz MD, PhD, Tim Jansen MD, Anne-Katrin Tausche MD, Mónica Juárez-Campo BSc, Ravichandra Karra Gurunath MD, Pascal Richette MD, PhD

Article Type

Review

Published

15 May 2019

The review aims to review current evidence about the efficacy and safety of lesinurad in combination with xanthine oxidase inhibitors in the treatment of hyperuricemia in patients with gout.

Effectiveness and safety of mepolizumab in severe refractory eosinophilic asthma: results in clinical practice

Olalla Montero-Pérez PharmD, María Beatriz Contreras-Rey PharmD, Ernesto Sánchez-Gómez PhD

Article Type

Original Research

Published

27 May 2019

This article analyses the effectiveness, clinical outcomes, and safety of mepolizumab in clinical practice.

Brodalumab in psoriasis: evidence to date and clinical potential

Amy C Foulkes BMedSci (Hons), BMBS, MRCP (Derm), PhD, Richard B Warren BSc (Hons), MBChB (Hons), MRCP, PhD

Article Type

Review

Published

17 Apr 2019

This article reviews brodalumab’s place in the expanding armamentarium of cytokine-directed therapies for patients with severe psoriasis.